1. Home
  2. ZLAB vs SXI Comparison

ZLAB vs SXI Comparison

Compare ZLAB & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SXI
  • Stock Information
  • Founded
  • ZLAB 2013
  • SXI 1955
  • Country
  • ZLAB China
  • SXI United States
  • Employees
  • ZLAB N/A
  • SXI N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SXI Industrial Machinery/Components
  • Sector
  • ZLAB Health Care
  • SXI Industrials
  • Exchange
  • ZLAB Nasdaq
  • SXI Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • SXI 2.3B
  • IPO Year
  • ZLAB 2017
  • SXI N/A
  • Fundamental
  • Price
  • ZLAB $32.54
  • SXI $163.12
  • Analyst Decision
  • ZLAB Buy
  • SXI Strong Buy
  • Analyst Count
  • ZLAB 5
  • SXI 3
  • Target Price
  • ZLAB $54.28
  • SXI $223.33
  • AVG Volume (30 Days)
  • ZLAB 781.8K
  • SXI 141.5K
  • Earning Date
  • ZLAB 08-05-2025
  • SXI 07-31-2025
  • Dividend Yield
  • ZLAB N/A
  • SXI 0.79%
  • EPS Growth
  • ZLAB N/A
  • SXI N/A
  • EPS
  • ZLAB N/A
  • SXI 5.04
  • Revenue
  • ZLAB $418,326,000.00
  • SXI $748,252,000.00
  • Revenue This Year
  • ZLAB $44.07
  • SXI $9.67
  • Revenue Next Year
  • ZLAB $49.13
  • SXI $12.91
  • P/E Ratio
  • ZLAB N/A
  • SXI $32.38
  • Revenue Growth
  • ZLAB 43.72
  • SXI 2.67
  • 52 Week Low
  • ZLAB $16.01
  • SXI $128.85
  • 52 Week High
  • ZLAB $44.34
  • SXI $212.66
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • SXI 55.30
  • Support Level
  • ZLAB $34.26
  • SXI $163.30
  • Resistance Level
  • ZLAB $35.72
  • SXI $169.98
  • Average True Range (ATR)
  • ZLAB 1.12
  • SXI 4.51
  • MACD
  • ZLAB -0.54
  • SXI 0.39
  • Stochastic Oscillator
  • ZLAB 3.83
  • SXI 56.05

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

Share on Social Networks: